Funding
Open Access funding enabled and organized by Projekt DEAL. The trial will be co-financed by funds of the German Research Organization (DFG- SCHL 2118/2-1). The study is supported by Daiichi Sankyo Europe GmbH. Study drug will be provided free of charge by Daiichi Sankyo Europe GmbH.The funding organizations did not influence the study design, nor will they influence the results of this trial.